25 XP   0   0   10

Zai Lab Ltd
Buy, Hold or Sell?

Let's analyse Zai Lab Ltd together

PenkeI guess you are interested in Zai Lab Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zai Lab Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zai Lab Ltd

I send you an email if I find something interesting about Zai Lab Ltd.

Quick analysis of Zai Lab Ltd (30 sec.)










What can you expect buying and holding a share of Zai Lab Ltd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
9.1%

What is your share worth?

Current worth
$8.02
Expected worth in 1 year
$5.51
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$-2.51
Return On Investment
-16.8%

For what price can you sell your share?

Current Price per Share
$14.99
Expected price per share
$0 - $21.88
How sure are you?
50%

1. Valuation of Zai Lab Ltd (5 min.)




Live pricePrice per Share (EOD)

$14.99

Intrinsic Value Per Share

$-13.53 - $-14.58

Total Value Per Share

$-5.51 - $-6.56

2. Growth of Zai Lab Ltd (5 min.)




Is Zai Lab Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$796.1m$1.1b-$265.2m-29.4%

How much money is Zai Lab Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$78.5m-$101.5m$22.9m29.2%
Net Profit Margin-116.6%-195.5%--

How much money comes from the company's main activities?

3. Financial Health of Zai Lab Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#68 / 1011

Most Revenue
#128 / 1011

Most Profit
#945 / 1011

Most Efficient
#580 / 1011

What can you expect buying and holding a share of Zai Lab Ltd? (5 min.)

Welcome investor! Zai Lab Ltd's management wants to use your money to grow the business. In return you get a share of Zai Lab Ltd.

What can you expect buying and holding a share of Zai Lab Ltd?

First you should know what it really means to hold a share of Zai Lab Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zai Lab Ltd is $14.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zai Lab Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zai Lab Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.02. Based on the TTM, the Book Value Change Per Share is $-0.63 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.84 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zai Lab Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.96-6.4%-1.02-6.8%-1.12-7.5%-1.01-6.7%-0.70-4.7%
Usd Book Value Change Per Share-0.86-5.7%-0.63-4.2%-0.84-5.6%0.271.8%0.241.6%
Usd Dividend Per Share0.000.0%0.000.0%0.020.1%0.151.0%0.090.6%
Usd Total Gains Per Share-0.86-5.7%-0.63-4.2%-0.82-5.5%0.422.8%0.332.2%
Usd Price Per Share27.33-28.16-35.89-61.26-41.24-
Price to Earnings Ratio-7.10--7.08--9.27--17.61--14.13-
Price-to-Total Gains Ratio-31.95--48.31--46.93--26.98--23.98-
Price to Book Ratio3.41-3.10-3.04-8.15-6.69-
Price-to-Total Gains Ratio-31.95--48.31--46.93--26.98--23.98-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share14.99
Number of shares66
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.15
Usd Book Value Change Per Share-0.630.27
Usd Total Gains Per Share-0.630.42
Gains per Quarter (66 shares)-41.4927.99
Gains per Year (66 shares)-165.97111.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-166-1763973102
20-332-34279145214
30-498-508118218326
40-664-674158290438
50-830-840197363550
60-996-1006237435662
70-1162-1172276508774
80-1328-1338316580886
90-1494-1504355653998
100-1660-16703957251110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.032.00.03.0%1.032.00.03.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.013.03.020.0%9.016.08.027.3%9.016.08.027.3%
Dividend per Share0.00.04.00.0%1.00.011.08.3%3.00.017.015.0%3.00.030.09.1%3.00.030.09.1%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%6.012.02.030.0%11.015.07.033.3%11.015.07.033.3%

Fundamentals of Zai Lab Ltd

About Zai Lab Ltd

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT. The company was incorporated in 2013 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2024-04-13 03:48:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zai Lab Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zai Lab Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Zai Lab Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -145.0% means that $-1.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zai Lab Ltd:

  • The MRQ is -145.0%. The company is making a huge loss. -2
  • The TTM is -116.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-145.0%TTM-116.6%-28.4%
TTM-116.6%YOY-195.5%+79.0%
TTM-116.6%5Y-662.3%+545.7%
5Y-662.3%10Y-3,486.9%+2,824.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-145.0%-196.1%+51.1%
TTM-116.6%-211.9%+95.3%
YOY-195.5%-277.7%+82.2%
5Y-662.3%-432.9%-229.4%
10Y-3,486.9%-599.3%-2,887.6%
1.1.2. Return on Assets

Shows how efficient Zai Lab Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zai Lab Ltd to the Biotechnology industry mean.
  • -9.2% Return on Assets means that Zai Lab Ltd generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zai Lab Ltd:

  • The MRQ is -9.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.2%TTM-7.3%-1.9%
TTM-7.3%YOY-7.4%+0.1%
TTM-7.3%5Y-10.4%+3.1%
5Y-10.4%10Y-16.4%+6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.2%-13.3%+4.1%
TTM-7.3%-12.7%+5.4%
YOY-7.4%-11.8%+4.4%
5Y-10.4%-14.0%+3.6%
10Y-16.4%-15.9%-0.5%
1.1.3. Return on Equity

Shows how efficient Zai Lab Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zai Lab Ltd to the Biotechnology industry mean.
  • -12.0% Return on Equity means Zai Lab Ltd generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zai Lab Ltd:

  • The MRQ is -12.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.0%TTM-8.9%-3.1%
TTM-8.9%YOY-8.6%-0.3%
TTM-8.9%5Y-12.2%+3.2%
5Y-12.2%10Y-19.6%+7.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.0%-16.9%+4.9%
TTM-8.9%-16.0%+7.1%
YOY-8.6%-15.1%+6.5%
5Y-12.2%-19.7%+7.5%
10Y-19.6%-20.5%+0.9%

1.2. Operating Efficiency of Zai Lab Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zai Lab Ltd is operating .

  • Measures how much profit Zai Lab Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zai Lab Ltd to the Biotechnology industry mean.
  • An Operating Margin of -188.3% means the company generated $-1.88  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zai Lab Ltd:

  • The MRQ is -188.3%. The company is operating very inefficient. -2
  • The TTM is -131.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-188.3%TTM-131.6%-56.8%
TTM-131.6%YOY-188.6%+57.1%
TTM-131.6%5Y-698.2%+566.6%
5Y-698.2%10Y-3,559.5%+2,861.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-188.3%-290.9%+102.6%
TTM-131.6%-224.4%+92.8%
YOY-188.6%-288.3%+99.7%
5Y-698.2%-479.5%-218.7%
10Y-3,559.5%-625.2%-2,934.3%
1.2.2. Operating Ratio

Measures how efficient Zai Lab Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.88 means that the operating costs are $2.88 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Zai Lab Ltd:

  • The MRQ is 2.883. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.411. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.883TTM2.411+0.473
TTM2.411YOY2.886-0.476
TTM2.4115Y8.061-5.651
5Y8.06110Y36.528-28.467
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8833.110-0.227
TTM2.4113.266-0.855
YOY2.8863.783-0.897
5Y8.0615.657+2.404
10Y36.5287.783+28.745

1.3. Liquidity of Zai Lab Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zai Lab Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.63 means the company has $4.63 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Zai Lab Ltd:

  • The MRQ is 4.627. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.138. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.627TTM7.138-2.510
TTM7.138YOY8.180-1.043
TTM7.1385Y8.779-1.642
5Y8.77910Y9.608-0.829
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6273.905+0.722
TTM7.1384.212+2.926
YOY8.1805.337+2.843
5Y8.7796.062+2.717
10Y9.6086.401+3.207
1.3.2. Quick Ratio

Measures if Zai Lab Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zai Lab Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 4.37 means the company can pay off $4.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zai Lab Ltd:

  • The MRQ is 4.373. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.817. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.373TTM6.817-2.443
TTM6.817YOY9.459-2.643
TTM6.8175Y10.784-3.967
5Y10.78410Y11.042-0.258
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3733.572+0.801
TTM6.8174.001+2.816
YOY9.4595.364+4.095
5Y10.7846.009+4.775
10Y11.0426.287+4.755

1.4. Solvency of Zai Lab Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zai Lab Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zai Lab Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Zai Lab Ltd assets are financed with 23.2% credit (debt) and the remaining percentage (100% - 23.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zai Lab Ltd:

  • The MRQ is 0.232. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.172. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.232TTM0.172+0.059
TTM0.172YOY0.141+0.031
TTM0.1725Y0.141+0.031
5Y0.14110Y0.233-0.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2320.336-0.104
TTM0.1720.334-0.162
YOY0.1410.271-0.130
5Y0.1410.366-0.225
10Y0.2330.389-0.156
1.4.2. Debt to Equity Ratio

Measures if Zai Lab Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zai Lab Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 30.2% means that company has $0.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zai Lab Ltd:

  • The MRQ is 0.302. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.210. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.302TTM0.210+0.091
TTM0.210YOY0.165+0.046
TTM0.2105Y0.166+0.045
5Y0.16610Y0.162+0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3020.382-0.080
TTM0.2100.397-0.187
YOY0.1650.341-0.176
5Y0.1660.432-0.266
10Y0.1620.465-0.303

2. Market Valuation of Zai Lab Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Zai Lab Ltd generates.

  • Above 15 is considered overpriced but always compare Zai Lab Ltd to the Biotechnology industry mean.
  • A PE ratio of -7.10 means the investor is paying $-7.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zai Lab Ltd:

  • The EOD is -3.896. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.103. Based on the earnings, the company is expensive. -2
  • The TTM is -7.084. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.896MRQ-7.103+3.207
MRQ-7.103TTM-7.084-0.019
TTM-7.084YOY-9.266+2.182
TTM-7.0845Y-17.615+10.531
5Y-17.61510Y-14.130-3.485
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.896-2.262-1.634
MRQ-7.103-2.599-4.504
TTM-7.084-2.674-4.410
YOY-9.266-4.133-5.133
5Y-17.615-6.258-11.357
10Y-14.130-6.171-7.959
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zai Lab Ltd:

  • The EOD is -23.590. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -43.010. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.044. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-23.590MRQ-43.010+19.420
MRQ-43.010TTM-19.044-23.967
TTM-19.044YOY-10.500-8.543
TTM-19.0445Y-22.919+3.875
5Y-22.91910Y-12.054-10.865
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-23.590-2.913-20.677
MRQ-43.010-3.275-39.735
TTM-19.044-3.508-15.536
YOY-10.500-5.620-4.880
5Y-22.919-8.306-14.613
10Y-12.054-8.854-3.200
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zai Lab Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.41 means the investor is paying $3.41 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Zai Lab Ltd:

  • The EOD is 1.868. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.406. Based on the equity, the company is fair priced.
  • The TTM is 3.097. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.868MRQ3.406-1.538
MRQ3.406TTM3.097+0.308
TTM3.097YOY3.039+0.059
TTM3.0975Y8.154-5.056
5Y8.15410Y6.694+1.460
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.8681.858+0.010
MRQ3.4062.090+1.316
TTM3.0972.091+1.006
YOY3.0392.866+0.173
5Y8.1543.488+4.666
10Y6.6943.836+2.858
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Zai Lab Ltd.

3.1. Institutions holding Zai Lab Ltd

Institutions are holding 44.844% of the shares of Zai Lab Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Wellington Management Company LLP5.3790.027253364573413829177.5606
2023-12-31Capital World Investors5.26050.0254521884300
2023-12-31HHG PLC4.07250.06594040282-202944-4.7828
2023-12-31T. Rowe Price Associates, Inc.2.7260.00992704455-12139-0.4468
2023-12-31Woodline Partners LP2.03460.599920185271217133151.877
2023-12-31Amvescap Plc.1.90860.01231893529-1315774-40.9987
2023-12-31Viking Global Investors LP1.88420.18711869283-621720-24.9586
2023-12-31Segantii Capital Management Ltd1.7012.43181687569-101430-5.6697
2023-12-31BAMCO Inc1.50280.10851490874-88475-5.602
2023-12-31FMR Inc1.24680.00261236927-31275-2.4661
2023-12-31Rock Springs Capital Management LP1.14610.7651137023-100000-8.0839
2023-12-31Paradigm Biocapital Advisors LP1.10051.3971091779-50604-4.4297
2023-12-31Legal & General Group PLC0.84110.005983445713983220.1306
2023-12-31ClearBridge Advisors, LLC0.830.01948234005120.0622
2023-12-31Capital Research & Mgmt Co - Division 30.81290.0049806453-38900-4.6016
2023-12-31Genesis Investment Management, LLP0.69823.7105692663-339503-32.8923
2023-12-31Allianz Asset Management AG0.68490.030367952414046126.0565
2023-12-31State Street Corporation0.66510.0009659805128441.9853
2023-12-31BlackRock Inc0.56510.0004560649311825.8893
2023-12-31M&G INVESTMENT MANAGEMENT LTD0.46140.0437457727-9264-1.9838
Total 35.52139.448635240226+2043765+5.8%

3.2. Funds holding Zai Lab Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31American Funds SMALLCAP World A3.12440.1177309966200
2023-12-31Vanguard Health Care Inv2.83650.165728140541728260159.1702
2023-12-31American Funds New World A2.23770.1134222004300
2023-12-31Invesco Emerging Markets Equity1.67880.20081665496-1159341-41.041
2023-12-31T. Rowe Price Health Sciences1.37390.2532136304712876510.4324
2023-12-31Janus Henderson Global Life Sciences1.33970.74161329076-36580-2.6786
2023-12-31Janus Henderson Global Life Sciences D1.33970.73811329076-36580-2.6786
2024-02-29Janus Henderson Glb Life Scn I2 USD1.18380.6193117444414861914.4878
2023-12-31Baron Emerging Markets Institutional1.15510.68591146006-83609-6.7996
2023-12-31Baron Emerging Markets Strategy1.15510.68971146006-83609-6.7996
2023-12-31Janus Selection Global Life Science AUSD1.0160.74491007970-37540-3.5906
2024-02-29Invesco Developing Markets A0.86170.0801854848-130308-13.2271
2023-12-31T. Rowe Price New Horizons0.75620.0829750187-172300-18.6778
2023-12-31US Small-Cap Growth II Equity Comp0.75620.0826750187-172300-18.6778
2024-03-28iShares Biotechnology ETF0.62780.130862283400
2023-12-31ClearBridge International Growth C0.58410.278457951800
2024-02-29ClearBridge International Growth EAFE0.58410.203857951800
2023-12-31Capital Group Global Equity Canada F0.55010.169254577500
2024-02-29Fidelity Growth Compy Commingled Pl O0.52840.01452419800
2024-02-29Wellington Global Hlthcr Eq USD G Ac0.49170.3895487836-14245-2.8372
Total 24.1816.501623989781+79232+0.3%

3.3. Insider Transactions

Insiders are holding 1.831% of the shares of Zai Lab Ltd.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-04Joshua L SmileySELL198815.67
2024-04-04Yajing ChenSELL84515.67
2024-04-02Frazor Titus Edmondson IiiSELL88516.15
2024-04-02Yajing ChenSELL51916.15
2024-04-02Ying DuSELL578716.15
2024-03-15Rafael AmadoSELL254418.86
2024-01-03Ying DuSELL838026.12
2024-01-02Rafael AmadoSELL1936326.3
2023-12-14Joshua L SmileyBUY400029.9
2023-11-16Joshua L SmileyBUY500026.93
2023-11-02Yajing ChenSELL16525.23

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Zai Lab Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.855-0.629-27%-0.843-1%0.275-411%0.243-452%
Book Value Per Share--8.0259.099-12%11.772-32%8.943-10%5.875+37%
Current Ratio--4.6277.138-35%8.180-43%8.779-47%9.608-52%
Debt To Asset Ratio--0.2320.172+34%0.141+64%0.141+64%0.2330%
Debt To Equity Ratio--0.3020.210+43%0.165+83%0.166+82%0.162+86%
Dividend Per Share----0%0.022-100%0.149-100%0.091-100%
Eps---0.962-1.024+6%-1.117+16%-1.006+5%-0.698-27%
Free Cash Flow Per Share---0.159-0.521+228%-0.989+523%-0.807+408%-0.574+261%
Free Cash Flow To Equity Per Share---0.155-0.537+247%-0.994+542%0.143-208%0.243-164%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.016-2%
Intrinsic Value_10Y_max---14.582--------
Intrinsic Value_10Y_min---13.534--------
Intrinsic Value_1Y_max---3.571--------
Intrinsic Value_1Y_min---3.509--------
Intrinsic Value_3Y_max---9.122--------
Intrinsic Value_3Y_min---8.741--------
Intrinsic Value_5Y_max---12.734--------
Intrinsic Value_5Y_min---11.958--------
Market Cap1487138472.960-82%2711373880.3202793469082.880-3%3560600386.560-24%6077971646.208-55%4091066320.524-34%
Net Profit Margin---1.450-1.166-20%-1.955+35%-6.623+357%-34.869+2305%
Operating Margin---1.883-1.316-30%-1.886+0%-6.982+271%-35.595+1790%
Operating Ratio--2.8832.411+20%2.8860%8.061-64%36.528-92%
Pb Ratio1.868-82%3.4063.097+10%3.039+12%8.154-58%6.694-49%
Pe Ratio-3.896+45%-7.103-7.0840%-9.266+30%-17.615+148%-14.130+99%
Price Per Share14.990-82%27.33028.158-3%35.890-24%61.265-55%41.237-34%
Price To Free Cash Flow Ratio-23.590+45%-43.010-19.044-56%-10.500-76%-22.919-47%-12.054-72%
Price To Total Gains Ratio-17.524+45%-31.951-48.310+51%-46.932+47%-26.981-16%-23.977-25%
Quick Ratio--4.3736.817-36%9.459-54%10.784-59%11.042-60%
Return On Assets---0.092-0.073-21%-0.074-20%-0.104+13%-0.164+79%
Return On Equity---0.120-0.089-26%-0.086-28%-0.122+1%-0.196+64%
Total Gains Per Share---0.855-0.629-27%-0.820-4%0.424-302%0.334-356%
Usd Book Value--796118000.000902663250.000-12%1167909250.000-32%887245714.600-10%582876986.667+37%
Usd Book Value Change Per Share---0.855-0.629-27%-0.843-1%0.275-411%0.243-452%
Usd Book Value Per Share--8.0259.099-12%11.772-32%8.943-10%5.875+37%
Usd Dividend Per Share----0%0.022-100%0.149-100%0.091-100%
Usd Eps---0.962-1.024+6%-1.117+16%-1.006+5%-0.698-27%
Usd Free Cash Flow---15760000.000-51667250.000+228%-98156500.000+523%-80042498.100+408%-55217642.848+250%
Usd Free Cash Flow Per Share---0.159-0.521+228%-0.989+523%-0.807+408%-0.574+261%
Usd Free Cash Flow To Equity Per Share---0.155-0.537+247%-0.994+542%0.143-208%0.243-164%
Usd Market Cap1487138472.960-82%2711373880.3202793469082.880-3%3560600386.560-24%6077971646.208-55%4091066320.524-34%
Usd Price Per Share14.990-82%27.33028.158-3%35.890-24%61.265-55%41.237-34%
Usd Profit---95429000.000-78560500.000-18%-101521000.000+6%-96135814.250+1%-66192906.697-31%
Usd Revenue--65830000.00066679750.000-1%53760250.000+22%34307588.350+92%20798361.970+217%
Usd Total Gains Per Share---0.855-0.629-27%-0.820-4%0.424-302%0.334-356%
 EOD+3 -5MRQTTM+11 -22YOY+15 -205Y+15 -2010Y+16 -20

4.2. Fundamental Score

Let's check the fundamental score of Zai Lab Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.896
Price to Book Ratio (EOD)Between0-11.868
Net Profit Margin (MRQ)Greater than0-1.450
Operating Margin (MRQ)Greater than0-1.883
Quick Ratio (MRQ)Greater than14.373
Current Ratio (MRQ)Greater than14.627
Debt to Asset Ratio (MRQ)Less than10.232
Debt to Equity Ratio (MRQ)Less than10.302
Return on Equity (MRQ)Greater than0.15-0.120
Return on Assets (MRQ)Greater than0.05-0.092
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Zai Lab Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.990
Ma 20Greater thanMa 5015.295
Ma 50Greater thanMa 10017.758
Ma 100Greater thanMa 20021.629
OpenGreater thanClose14.730
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,036,295
Total Liabilities240,177
Total Stockholder Equity796,118
 As reported
Total Liabilities 240,177
Total Stockholder Equity+ 796,118
Total Assets = 1,036,295

Assets

Total Assets1,036,295
Total Current Assets939,606
Long-term Assets96,689
Total Current Assets
Cash And Cash Equivalents 790,151
Short-term Investments 16,300
Net Receivables 65,333
Inventory 44,827
Other Current Assets 22,995
Total Current Assets  (as reported)939,606
Total Current Assets  (calculated)939,606
+/-0
Long-term Assets
Property Plant Equipment 68,689
Long Term Investments 9,220
Intangible Assets 16,458
Long-term Assets Other 4,278
Long-term Assets  (as reported)96,689
Long-term Assets  (calculated)98,645
+/- 1,956

Liabilities & Shareholders' Equity

Total Current Liabilities203,067
Long-term Liabilities37,110
Total Stockholder Equity796,118
Total Current Liabilities
Short-term Debt 7,104
Accounts payable 112,991
Other Current Liabilities 54,234
Total Current Liabilities  (as reported)203,067
Total Current Liabilities  (calculated)174,329
+/- 28,738
Long-term Liabilities
Capital Lease Obligations 15,151
Long-term Liabilities Other 325
Long-term Liabilities  (as reported)37,110
Long-term Liabilities  (calculated)15,476
+/- 21,634
Total Stockholder Equity
Common Stock6
Retained Earnings -2,195,980
Accumulated Other Comprehensive Income 37,626
Other Stockholders Equity 2,954,466
Total Stockholder Equity (as reported)796,118
Total Stockholder Equity (calculated)796,118
+/-0
Other
Capital Stock6
Cash and Short Term Investments 806,451
Common Stock Shares Outstanding 96,975
Current Deferred Revenue28,738
Liabilities and Stockholders Equity 1,036,295
Net Debt -775,000
Net Invested Capital 796,118
Net Working Capital 736,539
Property Plant and Equipment Gross 98,825
Short Long Term Debt Total 15,151



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
> Total Assets 
13,940
13,940
13,940
88,907
88,907
103,865
103,865
249,634
249,634
249,634
210,812
301,987
301,987
446,461
446,461
391,629
355,153
355,153
548,214
548,214
1,297,638
1,131,290
1,895,215
1,728,079
1,609,956
1,500,915
1,418,777
1,298,514
1,220,140
1,170,074
1,106,373
1,043,694
1,036,295
1,036,2951,043,6941,106,3731,170,0741,220,1401,298,5141,418,7771,500,9151,609,9561,728,0791,895,2151,131,2901,297,638548,214548,214355,153355,153391,629446,461446,461301,987301,987210,812249,634249,634249,634103,865103,86588,90788,90713,94013,94013,940
   > Total Current Assets 
13,230
13,161
0
84,092
84,092
93,882
93,882
230,615
230,615
230,615
182,406
269,144
269,144
401,798
401,798
329,305
292,464
292,464
484,881
1,216,036
1,216,036
1,049,185
1,808,603
1,619,087
1,500,881
1,393,251
1,335,647
1,209,831
1,124,336
1,072,298
1,017,505
959,731
939,606
939,606959,7311,017,5051,072,2981,124,3361,209,8311,335,6471,393,2511,500,8811,619,0871,808,6031,049,1851,216,0361,216,036484,881292,464292,464329,305401,798401,798269,144269,144182,406230,615230,615230,61593,88293,88284,09284,092013,16113,230
       Cash And Cash Equivalents 
13,161
-13,161
0
83,949
83,949
92,562
92,562
229,660
229,660
229,660
127,715
62,952
62,952
91,602
91,602
68,708
75,932
75,932
258,604
0
442,116
1,013,420
1,766,573
1,398,498
964,100
846,957
680,820
1,119,476
1,008,470
879,844
859,155
788,806
790,151
790,151788,806859,155879,8441,008,4701,119,476680,820846,957964,1001,398,4981,766,5731,013,420442,1160258,60475,93275,93268,70891,60291,60262,95262,952127,715229,660229,660229,66092,56292,56283,94983,9490-13,16113,161
       Short-term Investments 
0
26,321
0
0
0
0
0
0
0
50,000
50,000
200,350
200,350
301,600
301,600
251,600
200,000
200,000
205,000
0
744,676
744,676
0
170,000
445,000
465,274
575,274
0
0
50,550
15,500
31,600
16,300
16,30031,60015,50050,55000575,274465,274445,000170,0000744,676744,6760205,000200,000200,000251,600301,600301,600200,350200,35050,00050,000000000026,3210
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
90
90
2,483
2,483
3,917
3,791
3,791
7,024
5,165
5,165
8,815
18,029
21,018
54,809
44,242
38,241
39,067
48,571
60,727
68,064
65,275
65,333
65,33365,27568,06460,72748,57139,06738,24144,24254,80921,01818,0298,8155,1655,1657,0243,7913,7913,9172,4832,483909000000000000
       Other Current Assets 
69
0
0
144
144
1,320
1,320
955
955
955
4,691
5,749
5,749
5,971
5,971
4,191
6,736
6,736
7,684
10,935
10,935
14,321
12,887
17,077
18,021
16,490
17,973
22,157
35,674
42,772
38,433
29,821
22,995
22,99529,82138,43342,77235,67422,15717,97316,49018,02117,07712,88714,32110,93510,9357,6846,7366,7364,1915,9715,9715,7495,7494,6919559559551,3201,3201441440069
   > Long-term Assets 
0
0
0
1,753
4,815
7,051
9,983
13,524
19,020
19,020
28,406
0
32,843
33,102
44,663
62,324
62,689
62,689
63,333
0
81,602
82,105
86,612
108,992
109,075
107,664
83,130
88,683
95,804
97,776
88,868
83,963
96,689
96,68983,96388,86897,77695,80488,68383,130107,664109,075108,99286,61282,10581,602063,33362,68962,68962,32444,66333,10232,843028,40619,02019,02013,5249,9837,0514,8151,753000
       Property Plant Equipment 
707
0
0
1,246
2,663
7,044
7,044
11,854
11,980
11,980
20,393
20,494
20,770
29,605
29,605
35,677
44,080
44,080
35,329
46,863
47,137
45,912
50,503
53,730
58,280
67,191
69,557
74,865
78,771
80,178
75,612
71,824
68,689
68,68971,82475,61280,17878,77174,86569,55767,19158,28053,73050,50345,91247,13746,86335,32944,08044,08035,67729,60529,60520,77020,49420,39311,98011,98011,8547,0447,0442,6631,24600707
       Long Term Investments 
0
0
0
500
500
0
0
1,650
1,650
3,501
3,501
3,150
3,150
2,834
2,834
2,648
2,398
0
1,991
0
1,279
1,473
1,070
20,801
15,605
8,444
2,827
3,316
6,431
6,872
5,128
4,466
9,220
9,2204,4665,1286,8726,4313,3162,8278,44415,60520,8011,0701,4731,27901,99102,3982,6482,8342,8343,1503,1503,5013,5011,6501,65000500500000
       Intangible Assets 
3
0
0
7
7
6
6
20
20
20
0
322
322
664
664
8,624
8,803
8,803
8,632
0
9,440
9,369
9,582
9,427
9,659
9,519
8,959
8,364
8,403
8,399
4,757
4,625
16,458
16,4584,6254,7578,3998,4038,3648,9599,5199,6599,4279,5829,3699,44008,6328,8038,8038,62466466432232202020206677003
       Long-term Assets Other 
0
0
0
-1,753
3,062
-7,051
2,933
-13,524
5,369
5,369
4,512
0
8,601
-33,102
11,560
510
510
510
510
0
743
743
743
743
803
22,510
1,787
2,138
2,199
2,327
1,791
1,792
4,278
4,2781,7921,7912,3272,1992,1381,78722,510803743743743743051051051051011,560-33,1028,60104,5125,3695,369-13,5242,933-7,0513,062-1,753000
> Total Liabilities 
4,003
0
0
5,952
140,459
10,510
175,017
14,463
14,463
14,463
11,881
50,905
50,905
53,130
53,130
54,516
60,493
60,493
82,748
0
128,293
121,620
223,517
140,149
230,000
192,907
206,612
192,645
174,545
168,832
174,059
162,715
240,177
240,177162,715174,059168,832174,545192,645206,612192,907230,000140,149223,517121,620128,293082,74860,49360,49354,51653,13053,13050,90550,90511,88114,46314,46314,463175,01710,510140,4595,952004,003
   > Total Current Liabilities 
3,941
0
0
5,173
5,173
9,630
9,630
12,069
12,069
12,069
10,259
48,841
48,841
45,969
45,969
41,051
46,635
46,635
56,555
98,043
98,043
92,656
193,917
112,010
192,901
154,912
168,877
155,548
139,842
124,560
133,354
124,896
203,067
203,067124,896133,354124,560139,842155,548168,877154,912192,901112,010193,91792,65698,04398,04356,55546,63546,63541,05145,96945,96948,84148,84110,25912,06912,06912,0699,6309,6305,1735,173003,941
       Short-term Debt 
0
0
0
0
0
0
0
0
-2,394,124
-2,394,124
756
0
3,643
3,643
8,718
10,151
10,801
10,801
8,413
0
5,206
5,602
6,371
6,312
5,927
6,795
6,824
6,980
7,050
7,318
7,299
6,886
7,104
7,1046,8867,2997,3187,0506,9806,8246,7955,9276,3126,3715,6025,20608,41310,80110,80110,1518,7183,6433,6430756-2,394,124-2,394,12400000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
756
756
0
0
0
5,818
6,362
6,450
0
4,238
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000004,23806,4506,3625,818000756756000000000
       Accounts payable 
1,453
0
0
523
523
3,971
3,971
8,968
8,968
8,968
5,727
37,432
37,432
27,726
27,726
20,456
22,660
22,660
32,392
62,641
62,641
41,415
125,621
51,406
126,163
98,161
108,443
90,112
65,974
66,361
67,031
55,020
112,991
112,99155,02067,03166,36165,97490,112108,44398,161126,16351,406125,62141,41562,64162,64132,39222,66022,66020,45627,72627,72637,43237,4325,7278,9688,9688,9683,9713,971523523001,453
       Other Current Liabilities 
2,488
0
0
4,650
4,650
5,658
5,658
3,101
3,101
3,101
3,777
2,504
-2,056,175
18,244
9,526
10,443
10,293
10,293
4,923
6,307
13,338
42,359
44,293
36,805
33,325
23,060
28,835
35,251
45,458
19,913
30,399
35,304
54,234
54,23435,30430,39919,91345,45835,25128,83523,06033,32536,80544,29342,35913,3386,3074,92310,29310,29310,4439,52618,244-2,056,1752,5043,7773,1013,1013,1015,6585,6584,6504,650002,488
   > Long-term Liabilities 
0
0
0
0
135,286
0
165,387
0
2,394
2,394
1,622
0
2,064
2,064
7,161
13,465
13,858
13,858
26,193
0
30,250
28,964
29,600
28,139
37,099
37,995
37,735
37,097
34,703
44,272
40,705
37,819
37,110
37,11037,81940,70544,27234,70337,09737,73537,99537,09928,13929,60028,96430,250026,19313,85813,85813,4657,1612,0642,06401,6222,3942,3940165,3870135,2860000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
2,394,124
2,394,124
-756
0
-3,643
-3,643
-1,172
4,341
4,527
-10,801
6,219
0
13,392
12,307
11,968
10,652
9,613
11,099
12,960
13,892
13,343
12,979
11,755
9,808
8,047
8,0479,80811,75512,97913,34313,89212,96011,0999,61310,65211,96812,30713,39206,219-10,8014,5274,341-1,172-3,643-3,6430-7562,394,1242,394,12400000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
325
325
325
325
32532532532500000000000000000000000000000
> Total Stockholder Equity
9,937
9,937
0
82,955
-51,552
93,356
-71,152
235,171
235,171
235,171
198,931
251,082
251,082
393,330
393,330
337,113
294,660
294,660
465,466
0
1,169,345
1,009,670
1,671,698
1,587,930
1,379,956
1,308,008
1,212,165
1,105,869
1,045,595
1,001,242
932,314
880,979
796,118
796,118880,979932,3141,001,2421,045,5951,105,8691,212,1651,308,0081,379,9561,587,9301,671,6981,009,6701,169,3450465,466294,660294,660337,113393,330393,330251,082251,082198,931235,171235,171235,171-71,15293,356-51,55282,95509,9379,937
   Common Stock
1
0
0
1
1
1
1
3
3
3
198,931
3
3
393,330
393,330
4
4
4
4
5
5
5
6
6
6
6
6
6
6
6
6
6
6
666666666665554444393,330393,33033198,9313331111001
   Retained Earnings Total Equity000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-699
0
-322
0
450
450
0
0
2,662
-2,208
0
6,970
4,620
4,620
6,986
0
-14,524
-11,624
-16,865
-15,124
-23,645
-25,838
4,487
39,549
25,685
17,272
52,180
47,952
37,626
37,62647,95252,18017,27225,68539,5494,487-25,838-23,645-15,124-16,865-11,624-14,52406,9864,6204,6206,9700-2,2082,662004504500-3220-6990000
   Capital Surplus 
0
0
0
0
0
0
13,757
0
345,270
0
0
0
498,043
0
0
728,406
734,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000734,734728,40600498,043000345,270013,757000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
-104
-18,370
0
8,615
9,314
13,435
13,757
345,720
345,270
345,270
198,931
2,662
498,043
0
393,330
728,406
734,734
734,734
1,031,791
-14,524
1,897,467
1,967,802
2,798,394
2,809,297
2,821,669
2,834,308
2,846,073
2,865,905
2,881,264
2,894,468
2,911,527
2,933,572
2,954,466
2,954,4662,933,5722,911,5272,894,4682,881,2642,865,9052,846,0732,834,3082,821,6692,809,2972,798,3941,967,8021,897,467-14,5241,031,791734,734734,734728,406393,3300498,0432,662198,931345,270345,270345,72013,75713,4359,3148,6150-18,370-104



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue266,719
Cost of Revenue-95,816
Gross Profit170,903170,903
 
Operating Income (+$)
Gross Profit170,903
Operating Expense-547,476
Operating Income-376,573-376,573
 
Operating Expense (+$)
Research Development265,868
Selling General Administrative281,608
Selling And Marketing Expenses0
Operating Expense547,476547,476
 
Net Interest Income (+$)
Interest Income38,840
Interest Expense-0
Other Finance Cost-0
Net Interest Income38,840
 
Pretax Income (+$)
Operating Income-376,573
Net Interest Income38,840
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-334,620-418,526
EBIT - interestExpense = -376,573
-334,620
-334,620
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-376,573-334,620
Earnings Before Interest and Taxes (EBITDA)-358,836
 
After tax Income (+$)
Income Before Tax-334,620
Tax Provision-0
Net Income From Continuing Ops-300,960-334,620
Net Income-334,620
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses643,292
Total Other Income/Expenses Net41,953-38,840
 

Technical Analysis of Zai Lab Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zai Lab Ltd. The general trend of Zai Lab Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zai Lab Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zai Lab Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 17.69 < 18.72 < 21.88.

The bearish price targets are: .

Tweet this
Zai Lab Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zai Lab Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zai Lab Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zai Lab Ltd. The current macd is -1.08487255.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zai Lab Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zai Lab Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zai Lab Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zai Lab Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZai Lab Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zai Lab Ltd. The current adx is 30.74.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zai Lab Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Zai Lab Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zai Lab Ltd. The current sar is 13.48.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zai Lab Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zai Lab Ltd. The current rsi is 41.99. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zai Lab Ltd Daily Relative Strength Index (RSI) ChartZai Lab Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zai Lab Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zai Lab Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zai Lab Ltd Daily Stochastic Oscillator ChartZai Lab Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zai Lab Ltd. The current cci is -36.29083162.

Zai Lab Ltd Daily Commodity Channel Index (CCI) ChartZai Lab Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zai Lab Ltd. The current cmo is -5.76180894.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zai Lab Ltd Daily Chande Momentum Oscillator (CMO) ChartZai Lab Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zai Lab Ltd. The current willr is -43.01886792.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zai Lab Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zai Lab Ltd Daily Williams %R ChartZai Lab Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zai Lab Ltd.

Zai Lab Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zai Lab Ltd. The current atr is 0.80269554.

Zai Lab Ltd Daily Average True Range (ATR) ChartZai Lab Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zai Lab Ltd. The current obv is -6,130,210.

Zai Lab Ltd Daily On-Balance Volume (OBV) ChartZai Lab Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zai Lab Ltd. The current mfi is 42.11.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zai Lab Ltd Daily Money Flow Index (MFI) ChartZai Lab Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zai Lab Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Zai Lab Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zai Lab Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.990
Ma 20Greater thanMa 5015.295
Ma 50Greater thanMa 10017.758
Ma 100Greater thanMa 20021.629
OpenGreater thanClose14.730
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zai Lab Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zai Lab Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zai Lab Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zai Lab Ltd

I send you an email if I find something interesting about Zai Lab Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zai Lab Ltd.

Receive notifications about Zai Lab Ltd in your mailbox!